Speeding Study Start-Up in Multicenter Clinical Trials

Provided By:

Schulman IRB

July 28, 2016

Managing an efficient, well-organized start-up phase is critical to overall study success. While IRB review is just one element of the study start-up process, the IRB can play a crucial role in reaching key study milestones in multisite clinical trials for sponsors, CROs and research sites. By following a few simple steps, you can see a significant reduction in time spent on the initial IRB review process, which can influence and improve overall study timelines and success.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK